Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)

Condition:   ITP Intervention:   Drug: TPO Sponsor:   Shenyang Sunshine Pharmaceutical Co., LTD. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials